A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2018
A multicenter study to evaluate the efficacy and safety of maintenance and long-term treatment administration of upadacitinib, an orally administered Janus kinase 1 inhibitor, in adult participants with Crohn\'s Disease.
Epistemonikos ID: 013d6b29ef5f5a90e3bff188626801a22c2fc64f
First added on: Oct 03, 2023